A detailed history of Intech Investment Management LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 56,412 shares of AUPH stock, worth $865,924. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,412
Previous 68,473 17.61%
Holding current value
$865,924
Previous $579,000 7.6%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$7.47 - $13.14 $90,095 - $158,481
-12,061 Reduced 17.61%
56,412 $623,000
Q2 2025

Aug 08, 2025

SELL
$7.2 - $8.64 $91,526 - $109,831
-12,712 Reduced 15.66%
68,473 $579,000
Q1 2025

May 20, 2025

BUY
$7.55 - $8.77 $192,993 - $224,178
25,562 Added 45.96%
81,185 $652,000
Q4 2024

Feb 10, 2025

BUY
$6.75 - $10.44 $134,358 - $207,808
19,905 Added 55.73%
55,623 $499,000
Q3 2024

Nov 08, 2024

BUY
$5.32 - $7.33 $190,019 - $261,812
35,718 New
35,718 $261,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $2.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.